Clinical trial
Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN) in Patients Receiving Taxane Therapy for Breast Cancer.
NCT07779135 is registered in ClinicalTrials.gov with Centre Hospitalier de Colmar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN) in Patients Receiving Taxane Therapy for Breast Cancer.
- Lead sponsor
- Centre Hospitalier de Colmar
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 15, 2026
- Completion date
- September 15, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, neuropathic pain in cancer